Subclinical hypothyroidism and vascular risk: An update

Hormones

Volumn 12, Issue 4, 2013, Pages 495-506

  Lioudaki, Eirini ^a   Mavroeidi, Niki G ^a   Mikhailidis, Dimitri P ^b   Ganotakis, Emmanouel S ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Cardiovascular disease; Carotid; Lipids; Subclinical hypothyroidism

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEVOTHYROXINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; THYROTROPIN;

ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RESPONSE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DRUG EFFICACY; DRUG RESPONSE; DYSLIPIDEMIA; HUMAN; ISCHEMIC HEART DISEASE; POPULATION RESEARCH; PREVALENCE; REVIEW; RISK REDUCTION; SUBCLINICAL HYPOTHYROIDISM; SYSTEMATIC REVIEW; THYROTROPIN BLOOD LEVEL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

CARDIOVASCULAR DISEASES; HUMANS; HYPOTHYROIDISM; LIPIDS; RISK FACTORS; THYROXINE; TREATMENT OUTCOME;

EID: 84891544549     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1437     Document Type: Review

References (114)

1. Garber JR, Cobin RH, Gharib H, et al, 2012 Clinical practice guidelines for hypothyroidism in adults: cosponsored by the american association of Clinical endocrinologists and the american Thyroid association. Endocr Pract 18: 988-1028.
2. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC 2000 The Colorado Thyroid Disease Prevalence Study. Arch intern Med 160: 526-534.
3. Hollowell JG, Staehling NW, Flanders WD, et al, 2002 Serum TSH, T(4), and thyroid antibodies in the united States population (1988 to 1994): National Health and Nutrition examination Survey (NHaNeS iii). J Clin endocrinol Metab 87: 489-499.
4. Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J, 2004 Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin endocrinol (oxf) 61: 232-238.
5. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P, 1985 The aging thyroid. Thyroid deficiency in the Framingham Study. Arch intern Med 145: 1386-1388.
6. Surks MI, Ortiz E, Daniels GH, et al, 2004 Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291: 228-238.
7. Neves C, alves M, Medina JL, Delgado JL, 2008 Thyroid diseases, dyslipidemia and cardiovascular pathology. Rev Port Cardiol 27: 1211-1236.
8. Pucci E, Chiovato L, Pinchera A, 2000 Thyroid and lipid metabolism. Int J obes relat Metab Disord 24: Suppl 2: 109-112.
9. Duntas LH, 2002 Thyroid disease and lipids. Thyroid 12: 287-293.
10. Walsh JP, Bremner AP, Bulsara MK, et al, 2005 Thyroid dysfunction and serum lipids: a community-based study. Clin endocrinol (oxf) 63: 670-675.
11. 1994 National Cholesterol education Program. Second report of the expert Panel on Detection, evaluation, and Treatment of High Blood Cholesterol in adults (adult Treatment Panel ii). Circulation 89: 1333-1445.
12. Marwaha RK, Tandon N, Garg MK, et al, 2011 Dys-lipidemia in subclinical hypothyroidism in an indian population. Clin Biochem 44: 1214-1217.
13. Kanaya AM, Harris F, Volpato S, et al, 2002 Association between thyroid dysfunction and total cholesterol level in an older biracial population: the health, aging and body composition study. Arch intern Med 162: 773-779.
14. Caraccio N, Ferrannini E, Monzani F, 2002 Lipoprotein profile in subclinical hypothyroidism: response to levo-thyroxine replacement, a randomized placebo-controlled study. J Clin endocrinol Metab 87: 1533-1538.
15. Efstathiadou Z, Bitsis S, Milionis HJ, et al, 2001 Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial? Eur J endocrinol 145: 705-710.
16. Kim SK, Kim SH, Park KS, Park SW, Cho YW, 2009 Regression of the increased common carotid artery-intima media thickness in subclinical hypothyroidism after thyroid hormone replacement. Endocr J 56: 753-758.
17. Miura S, Iitaka M, Yoshimura H, et al, 1994 Disturbed lipid metabolism in patients with subclinical hypothy-roidism: effect of L-thyroxine therapy. Intern Med 33: 413-417.
18. Ozcan O, Cakir E, Yaman H, et al, 2005 The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (aDMa) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism. Clin endocrinol (oxf) 63: 203-206.
19. Duntas LH, Brenta G, 2013 The effect of thyroid disorders on lipid levels and metabolism. Med Clin North am 96: 269-281.
20. De Teixeira PF, Reuters VS, Ferreira MM, et al, 2008 Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid failure. Transl res 151: 224-231.
21. Pearce EN, 2012 Update in lipid alterations in subclinical hypothyroidism. J Clin endocrinol Metab 97: 326-333.
22. Lee YK, Kim JE, oh HJ, et al, 2011 Serum TSH level in healthy Koreans and the association of TSH with serum lipid concentration and metabolic syndrome. Korean J intern Med 26: 432-439.
23. Wanjia X, Chenggang W, Aihong W, et al, 2012 A high normal TSH level is associated with an atherogenic lipid profile in euthyroid non-smokers with newly diagnosed asymptomatic coronary heart disease. Lipids Health Dis 11: 44.
24. Adrees M, Gibney J, El-Saeity N, Boran G 2009 Effects of 18 months of L-T4 replacement in women with subclinical hypothyroidism. Clin endocrinol (oxf) 71: 298-303.
25. Tzotzas T, Krassas GE, Konstantinidis T, Bougoulia M, 2000 Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment. Thyroid 10: 803-808.
26. Nordestgaard BG, Chapman MJ, ray K, et al, Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 31: 2844-2853.
27. Hueston WJ, Pearson WS, 2004 Subclinical hypothy-roidism and the risk of hypercholesterolemia. Ann Fam Med 2: 351-355.
28. Imaizumi M, Akahoshi M, Ichimaru S, et al, 2004 Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin endocrinol Metab 89: 3365-3370.
29. Lee W Y, Suh JY, Rhee EJ, et al, 2004 Plasma CrP, apolipoprotein a-1, apolipoprotein B and Lpa levels according to thyroid function status. Arch Med res 35: 540-545.
30. Pirich C, Mullner M, Sinzinger H, 2000 Prevalence and relevance of thyroid dysfunction in 1922 cholesterol screening participants. J Clin epidemiol 53: 623-629.
31. Arikan S, Bahceci M, Tuzcu A, Celik F, Gokalp D, 2012 Postprandial hyperlipidemia in overt and subclinical hypothyroidism. Eur J intern Med 23: e141-145.
32. Hernandez-Mijares A, Jover A, Bellod L, et al, 2013 Relation between lipoprotein subfractions and TSH levels in the cardiovascular risk among women with subclinical hypothyroidism. Clin endocrinol (oxf) 78: 777-782.
33. Kolovou GD, Mikhailidis DP, Kovar J, et al, 2011 Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. Curr Vasc Pharmacol 9: 258-270.
34. Kolovou GD, Mikhailidis DP, Nordestgaard BG, Bilianou H, Panotopoulos G, 2011 Definition of postprandial lipaemia. Curr Vasc Pharmacol 9: 292-301.
35. Mikhailidis DP, Elisaf M, Rizzo M, et al, 2011 "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. Curr Vasc Pharmacol 9: 533-571.
36. Mikhailidis DP, Elisaf M, Rizzo M, et al, 2011 "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary. Curr Vasc Pharmacol 9: 531-532.
37. Abbas JM, Chakraborty J, Akanji AO, Doi SA, 2008 Hypothyroidism results in small dense LDL independent of irS traits and hypertriglyceridemia. Endocr J 55: 381-389.
38. Lai CC, Tang SH, Pei D, et al, 2011 The prevalence of subclinical thyroid dysfunction and its association with metabolic syndrome in Taiwanese elderly. Int J geront 5: 25-29.
39. Park SB, Choi HC, Joo NS, 2011 The relation of thyroid function to components of the metabolic syndrome in Korean men and women. J Korean Med Sci 26: 540-545.
40. De Garduno-Garcia JJ, Alvirde-Garcia U, Lopez-Carrasco G, et al, 2011 TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J endocrinol 163: 273-278.
41. Wang J Y, Wang CY, Pei D, et al, 2012 Association between thyroid function and metabolic syndrome in elderly subjects. J am geriatr Soc 58: 1613-1614.
42. Wang CY, Chang TC, Chen MF, 2012 Associations between subclinical thyroid disease and metabolic syndrome. Endocr J 59: 911-917.
43. Canturk Z, Cetinarslan B, Tarkun I, et al, 2003 Hemo-static system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 13: 971-977.
44. Erem C, 2006 Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclini-cal hyperthyroidism increases plasma factor X activity. Clin endocrinol (oxf) 64: 323-329.
45. Erikci AA, Karagoz B, Ozturk A, et al, 2009 The effect of subclinical hypothyroidism on platelet parameters. Hematology 14: 115-117.
46. Fiarresga AJ, Feliciano J, Fernandes R, et al, 2009 Relationship between coronary disease and subclini-cal hypothyroidism: an angiographic study. Rev Port Cardiol 28: 535-543.
47. Gullu S, Sav H, Kamel N, 2005 Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism. Eur J endocrinol 152: 355-361.
48. Gunduz M, Gunduz E, Kircelli F, Okur N, Ozkaya M, 2012 Role of surrogate markers of atherosclerosis in clinical and subclinical thyroidism. Int J endocrinol 2012: 109797.
49. Owen PJ, Rajiv C, Vinereanu D, et al, 2006 Subclini-cal hypothyroidism, arterial stiffness, and myocardial reserve. J Clin endocrinol Metab 91: 2126-2132.
50. Peleg RK, Efrati S, Benbassat C, Fygenzo M, Golik A, 2008 The effect of levothyroxine on arterial stiffness and lipid profile in patients with subclinical hypothyroidism. Thyroid 18: 825-830.
51. Tian L, Gao C, Liu J, Zhang X, 2010 Increased carotid arterial stiffness in subclinical hypothyroidism. Eur J intern Med 21: 560-563.
52. Toruner F, Altinova AE, Karakoc A, et al, 2008 Risk factors for cardiovascular disease in patients with sub-clinical hypothyroidism. Adv Ther 25: 430-437.
53. Yilmaz H, Ertugrul O, Ertugrul B, Ertugrul D, 2011 Mean platelet volume in patients with subclinical hy-pothyroidism. Platelets 22: 143-147.
54. Danese MD, Ladenson PW, Meinert CL, Powe NR, 2000 Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin endocrinol Metab 85: 2993-3001.
55. Tanis BC, Westendorp GJ, Smelt HM, 1996 Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies. Clin endocrinol (oxf) 44: 643-649.
56. Meier C, Staub JJ, Roth CB, et al, 2001 TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin endocrinol Metab 86: 4860-4866.
57. Razvi S, Ingoe L, Keeka G, et al, 2007 The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin endocrinol Metab 92: 1715-1723.
58. Serter R, Demirbas B, Korukluoglu B, et al, 2004 The effect of L-thyroxine replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism. J endocrinol invest 27: 897-903.
59. Arinzon Z, Zuta A, Peisakh A, Feldman J, Berner Y, 2007 Evaluation response and effectiveness of thyroid hormone replacement treatment on lipid profile and function in elderly patients with subclinical hypothy-roidism. Arch gerontol geriatr 44: 13-19.
60. Ganotakis ES, Mandalaki K, Tampakaki M, et al, 2003 Subclinical hypothyroidism and lipid abnormalities in older women attending a vascular disease prevention clinic: effect of thyroid replacement therapy. Angiology 54: 569-576.
61. Perez A, Cubero JM, Sucunza N, et al, 2004 Emerging cardiovascular risk factors in subclinical hypothyroid-ism: lack of change after restoration of euthyroidism. Metabolism 53: 1512-1515.
62. Monzani F, Caraccio N, Kozakowa M, et al, 2004 Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. J Clin endo-crinol Metab 89: 2099-2106.
63. Tagami T, Tamanaha T, Shimazu S, et al, 2010 Lipid profiles in the untreated patients with Hashimoto thyroiditis and the effects of thyroxine treatment on subclinical hypothyroidism with Hashimoto thyroiditis. Endocr J 57: 253-258.
64. Iqbal A, Jorde R, Figenschau Y, 2006 Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromso Study. J intern Med 260: 53-61.
65. Ito M, Arishima T, Kudo T, et al, 2007 Effect of levo-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients. J Clin endocrinol Metab 92: 608-611.
66. Ito M, Kitanaka A, Arishima T, et al, 2012 Effect of L-thyroxine replacement on apolipoprotein B-48 in overt and subclinical hypothyroid patients. Endocr J 60: 65-71.
67. Cabral MD, Teixeira P, Soares D, et al, 2011 Effects of thyroxine replacement on endothelial function and carotid artery intima-media thickness in female patients with mild subclinical hypothyroidism. Clinics (Sao Paulo) 66: 1321-1328.
68. Duman D, Demirtunc R, Sahin S, Esertas K, 2007 The effects of simvastatin and levothyroxine on intima-media thickness of the carotid artery in female normolipemic patients with subclinical hypothyroidism: a prospective, randomized-controlled study. J Cardiovasc Med (Hagerstown) 8: 1007-1011.
69. Kong WM, Sheikh MH, Lumb PJ, et al, 2002 A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. Am J Med 112: 348-354.
70. Kowalska I, Borawski J, Nikolajuk A, et al, 2011 Insulin sensitivity, plasma adiponectin and siCaM-1 concentrations in patients with subclinical hypothyroid-ism: response to levothyroxine therapy. Endocrine 40: 95-101.
71. Paoli M, Bellabarba G, Velazquez E, et al, 1998 Sex steroids, lipids, and lipoprotein cholesterols in women with subclinical and overt hypothyroidism before and after L-thyroxine therapy. Clin Chim acta 275: 81-91.
72. Kebapcilar L, Comlekci A, Tuncel P, et al, 2010 Effect of levothyroxine replacement therapy on paraoxonase-1 and carotid intima-media thickness in subclinical hy-pothyroidism. Med Sci Monit 16: Cr41- Cr 47.
73. Caron P, Calazel C, Parra HJ, Hoff M, Louvet JP, 1990 Decreased HDL cholesterol in subclinical hypothyroid-ism: the effect of L-thyroxine therapy. Clin endocrinol (oxf) 33: 519-523.
74. Cappola AR, Ladenson PW, 2003 Hypothyroidism and atherosclerosis. J Clin endocrinol Metab 88: 2438-2444.
75. Cappola AR, Fried LP, Arnold AM, et al, 2006 Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295: 1033-1041.
76. Rodondi N, Newman AB, Vittinghoff E, et al, 2005 Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch intern Med 165: 2460-2466.
77. Hyland KA, arnold AM, Lee JS, Cappola AR, 2013 Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study. J Clin endocrinol Metab 98: 533-540.
78. Legrys VA, Funk MJ, Lorenz CE, et al, 2013 Subclinical hypothyroidism and risk for incident myocardial infarction among postmenopausal women. J Clin endocrinol Metab 98: 2308-2317.
79. Razvi S, Shakoor A, Vanderpump M, Weaver JU, Pearce SH, 2008 The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J Clin endocrinol Metab 93: 2998-3007.
80. Walsh JP, Bremner AP, Bulsara MK, et al, 2005 Subclini-cal thyroid dysfunction as a risk factor for cardiovascular disease. Arch intern Med 165: 2467-2472.
81. Triolo M, de Boer JF, Annema W, Kwakernaak AJ, Tietge UJ, Dullaart RP, 2012 Low normal free T4 confers decreased high density lipoprotein anti-oxidative functionality in the context of hyperglycemia. Clin endocrinol (oxf) 79: 416-423.
82. Erdem TY, Ercan M, Ugurlu S, et al, 2008 Plasma viscosity, an early cardiovascular risk factor in women with subclinical hypothyroidism. Clin Hemorheol Microcirc 38: 219-225
83. La Vignera S, Condorelli R, Vicari E, Calogero AE, Endothelial dysfunction and subclinical hypothyroid-ism: a brief review. J endocrinol invest 35: 96-103.
84. Sharma R, Sharma TK, Kaushik GG, et al, 2011 Sub-clinical hypothyroidism and its association with cardiovascular risk factors. Clin Lab 57: 719-724.
85. Otocka-Kmiecik A, Mikhailidis DP, Nicholls SJ, et al, 2012 Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease? Prog Lipid res 51: 314-324.
86. Ghasemi M, Mousavi SA, Rezvanian H, et al, 2010 Carotid intima-media thickness in subclinical hypo-thyroidism. Int J Stroke 5: 131-132.
87. Nagasaki T, Inaba M, Henmi Y, et al, 2003 Decrease in carotid intima-media thickness in hypothyroid patients after normalization of thyroid function. Clin endocrinol (oxf) 59: 607-612.
88. Gao N, Zhang W, Zhang YZ, Yang Q, Chen SH 2013 Carotid intima-media thickness in patients with subclini-cal hypothyroidism: a meta-analysis. Atherosclerosis 227: 18-25.
89. Taddei S, Caraccio N, Virdis A, et al, 2003 Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin endocrinol Metab 88: 3731-3737.
90. Shakoor SK, Aldibbiat A, Ingoe LE, et al, 2010 Endo-thelial progenitor cells in subclinical hypothyroidism: the effect of thyroid hormone replacement therapy. J Clin endocrinol Metab 95: 319-322.
91. Bastenie PA, Vanhaelst L, Bonnyns M, Neve P, Staquet M 1971 Preclinical hypothyroidism: a risk factor for coronary heart-disease. Lancet 1: 203-204.
92. Tieche M, Lupi GA, Gutzwiller F, et al, 1981 Borderline low thyroid function and thyroid autoimmunity. risk factors for coronary heart disease? Br Heart J 46: 202-206.
93. Hak AE, Pols HA, Visser TJ, et al, 2000 Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the rotterdam Study. Ann intern Med 132: 270-278.
94. Heinonen OP, Gordin A, Aho K, et al, 1972 Symptom- less autoimmune thyroiditis in coronary heart-disease. Lancet 1: 785-786.
95. Gasparyan AY, ayvazyan L, Mikhailidis DP, Kitas GD, 2011 Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 17: 47-58.
96. Yu YT, Ho CT, Hsu HS, et al, 2013 Subclinical hypo-thyroidism is associated with elevated high-sensitive C-reactive protein among adult Taiwanese. Endocrine [epub ahead of print].
97. Haidara M, Mikhailidis DP, Yassin HZ, et al, 2011 evaluation of the possible contribution of antioxidants administration in metabolic syndrome. Curr Pharm Des 17: 3699-3712.
98. Reddy VS, Gouroju S, Suchitra MM, et al, 2013 Anti-oxidant Defense in overt and Subclinical Hypothyroid-ism. Horm Metab res 45: 754-758.
99. Chung GE, Kim D, Kim W, et al, 2012 Non-alcoholic fatty liver disease across the spectrum of hypothyroid-ism. J Hepatol 57: 150-156.
100. Athyros VG, Tziomalos K, Daskalopoulos GN, Kara-giannis A, Mikhailidis DP, 2011 Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone? Ann Med 43: 167-171.
101. Athyros VG, Tziomalos K, Gossios TD, et al, 2010 Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the greek atorvas-tatin and Coronary Heart Disease evaluation (greaCe) Study: a post-hoc analysis. Lancet 376: 1916-1922.
102. Lioudaki E, Ganotakis ES, Mikhailidis DP, 2011 Liver enzymes: potential cardiovascular risk markers? Curr Pharm Des 17: 3632-3643.
103. Fabbrini E, Magkos F, Patterson BW, Mittendorfer B, Klein S, 2012 Subclinical hypothyroidism and hyperthyroidism have opposite effects on hepatic very-low-density lipoprotein-triglyceride kinetics. J Clin endocrinol Metab 97: e414-418.
104. Athyros VG, Mikhailidis DP, Didangelos TP, et al, 2006 Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study. Curr Med res opin 22: 873-883.
105. Nakajima Y, Yamada M, akuzawa M, et al, 2013 Subclinical hypothyroidism and indices for metabolic syndrome in Japanese women: one year follow-up study. J Clin endocrinol Metab 98: 3280-3287.
106. Asik M, Sahin S, Ozkul F, et al, 2013 Evaluation of epicardial fat tissue thickness in patients with Hashimoto thyroiditis. Clin endocrinol 79: 571-576.
107. Katsiki N, Mikhailidis DP, Wierzbicki AS, 2013 Epi-cardial fat and vascular risk: a narrative review. Curr opin Cardiol 28: 458-463.
108. Inal S, Karakoc MA, Kan E, et al, 2012 The effect of overt and subclinical hypothyroidism on the development of non-dipper blood pressure. Endokrynol Pol 63: 97-103.
109. Cai Y, Ren Y, Shi J 2011 Blood pressure levels in patients with subclinical thyroid dysfunction: a meta-analysis of cross-sectional data. Hypertens res 34: 1098-1105.
110. Genest J, McPherson R, Frohlich J, et al, 2009 Ca nadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol 25: 567-579.
111. Reiner Z, Catapano AL, De Backer G, et al, 2011 eSC/eaS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the european Society of Cardiology (eSC) and the european atherosclerosis Society (eaS). Eur Heart J 32: 1769-1818.
112. Shin DH, Lee MJ, Kim SJ, et al, 2012 Preservation of renal function by thyroid hormone replacement therapy in chronic kidney disease patients with subclinical hy-pothyroidism. J Clin endocrinol Metab 97: 2732-2740.
113. Rallidis LS, Fountoulaki K, Anastasiou-Nana M, 2012 Managing the underestimated risk of statin-associated myopathy. Int J Cardiol 159: 169-176.
114. Tseng FY, Lin WY, Lin CC, et al, 2012 Subclinical hypothyroidism is associated with increased risk for all-cause and cardiovascular mortality in adults. J am Coll Cardiol 60: 730-737.